Marshall Wace LLP decreased its stake in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF – Free Report) by 27.9% in the second quarter, Holdings Channel.com reports. The fund owned 25,276 shares of the company’s stock after selling 9,801 shares during the period. Marshall Wace LLP’s holdings in Bain Capital Specialty Finance were worth $412,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. BI Asset Management Fondsmaeglerselskab A S grew its holdings in Bain Capital Specialty Finance by 41.5% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 165,005 shares of the company’s stock valued at $2,587,000 after buying an additional 48,404 shares in the last quarter. Van ECK Associates Corp lifted its position in Bain Capital Specialty Finance by 13.4% during the first quarter. Van ECK Associates Corp now owns 886,423 shares of the company’s stock valued at $13,899,000 after purchasing an additional 104,422 shares during the last quarter. Confluence Investment Management LLC purchased a new position in shares of Bain Capital Specialty Finance in the 1st quarter worth $1,840,000. LSV Asset Management bought a new stake in shares of Bain Capital Specialty Finance in the 1st quarter worth about $847,000. Finally, Quadrature Capital Ltd raised its position in shares of Bain Capital Specialty Finance by 106.6% during the 4th quarter. Quadrature Capital Ltd now owns 83,362 shares of the company’s stock valued at $1,255,000 after buying an additional 43,005 shares in the last quarter.
Bain Capital Specialty Finance Stock Performance
BCSF opened at $16.57 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 1.03. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of 8.29 and a beta of 1.13. Bain Capital Specialty Finance, Inc. has a 12 month low of $14.60 and a 12 month high of $17.25. The stock has a fifty day moving average price of $16.59 and a 200-day moving average price of $16.43.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on BCSF. Wells Fargo & Company cut their target price on Bain Capital Specialty Finance from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Thursday, August 8th. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $17.00 target price on shares of Bain Capital Specialty Finance in a research note on Wednesday, August 21st.
Get Our Latest Analysis on BCSF
Bain Capital Specialty Finance Company Profile
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Featured Articles
- Five stocks we like better than Bain Capital Specialty Finance
- Best Stocks Under $5.00
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Want to see what other hedge funds are holding BCSF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bain Capital Specialty Finance, Inc. (NYSE:BCSF – Free Report).
Receive News & Ratings for Bain Capital Specialty Finance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bain Capital Specialty Finance and related companies with MarketBeat.com's FREE daily email newsletter.